Pain and Psychology—A Reciprocal Relationship

  • Ochsner Journal
  • June 2017,
  • 17
  • (2)
  • 173-180;

Abstract

Background: Depression typically affects 5% of the general population, but among patients with chronic pain, 30%-45% experience depression. Studies have shown that the relationship between depression and pain is bidirectional: depression is a positive predictor of the development of chronic pain, and chronic pain increases the risk of developing depression.

Methods: This literature review focuses on the relationship between psychology and pain, covering studies that have investigated the association between depression, pain sensitivity, opioid abuse, and gender differences in pain perception. We conducted a PubMed search pairing the word pain with depression, opioid use, and gender differences.

Results: The relationship between depression and pain is complex, as suggested by numerous studies that propose depression to be a moderator of the relationship between pain severity, physical functioning, and opioid use. Neuroimaging also suggests an anatomic overlap in the pathway of chronic pain and depression. Positive psychological factors, namely hope, pain acceptance, and optimism, affect the adjustment to persistent pain.

Conclusion: The intricate relationship between pain and psychology is evidenced by the clinical overlap in their presentations and the overlap between the anatomic regions in the brain associated with the emotional and sensory features of pain and the areas affected by depression. Studies are beginning to improve our understanding of these two systems, but more studies are needed to elucidate the relationship.

Keywords

INTRODUCTION

A significant reciprocal relationship between depressive symptoms and pain exists. Chronic pain is associated with a greater risk of developing or having depression,1 and epidemiologic studies indicate that up to 75% of patients with depression also report pain.2,3 Chronic pain is costly. Based on the 2008 Medical Expenditure Panel Survey, approximately 100 million adults in the United States reported chronic pain, and the estimated national annual cost is $635-$650 billion.4

Depression typically affects 5% of the general population, but among patients with chronic pain, 30%-45% experience depression.5,6 In a study of 18,980 subjects, 43.4% of individuals who met the criteria for major depressive disorder also met the criteria for chronic painful physical condition (CPPC), a percentage significantly higher than the 16.1% of the general population with CPPC.7 To meet the criteria for CPPC, the patient must have had pain for 6 months that led to medication use or consultation with a healthcare specialist. Of note, people who report CPPC also report worse symptoms of fatigue, diminished concentration, insomnia, and psychomotor retardation compared to people without pain.8

Depression is a mental disorder that consists of both somatic and emotional symptoms. The prevalence of physical and somatic symptoms existing concurrently in patients with major depressive disorder in tertiary care ranges from 30%-54%.9-11 Despite this knowledge, numerous studies have reported that depression is not assessed in up to half of patients experiencing physical symptoms,12 thereby increasing the risk of these patients developing more severe depression and greater treatment resistance.13

Chronic pain has been linked to reduced benefits from antidepressants and decreased quality of life.13 A population-based study reported that patients experiencing both depression and pain sought 20% more initial visits to medical providers and had higher total medical costs compared to patients with depression but no reports of pain.14 The findings of these studies show that patients with both pain and depression have higher medical costs and less treatment benefit than patients with depression only, creating problems with utilization of medical care and medical management. Another study furthered this point, reporting that more severe and longer duration depressive episodes occur among individuals who also report the presence of pain.15

Chronic pain and depression have common comorbidities, including greater levels of stress and sleep disturbance compared to patients without chronic pain or depression.16,17 The association between chronic pain and depression can in part be explained by a distorted sensitivity to pain. Although some experimental studies have demonstrated a positive association between negative emotions and greater pain,18 there is also evidence that negative emotions can reduce pain sensitivity.19,20 Rhudy and Williams have argued that this paradoxical finding can be explained by the type of emotion that is elicited by the degree of arousal or threat.21 In this school of thought, greater threats may elicit greater arousal, negative affect, and decreased sensitivity to pain, a phenomenon called stress-induced analgesia.22 On the other hand, lesser threats that elicit lower levels of arousal may lead to increased pain sensitivity.18 This paradox suggests that the relationship between pain and emotion is more multidimensional and complicated than originally perceived. Studies have shown that the relationship between depression and pain is bidirectional: depression is a positive predictor of the development of chronic pain, and chronic pain increases the risk of developing depression.23

NEUROBIOLOGIC BASIS OF THE RELATIONSHIP BETWEEN DEPRESSION AND PAIN

The dysregulation of noradrenergic and serotonergic pathways is common to both chronic pain and depression.24 Hyperactivation in the perigenual anterior cingulate cortex—an area that has been linked to pleasure and receives crucial connections from the dopamine system of the midbrain—has been reported in major depression.25 The mesolimbic dopamine system organizes the brain's response to rewarding vs painful stimuli, thereby driving the system to seek reward-oriented behaviors and avoid those that cause pain or negative feelings such as anxiety or depression.2 The mesolimbic dopamine systems and nucleus accumbens are stimulated in response to aversive, painful stimuli as well as to pleasurable stimuli.26 This finding suggests that in depression, the mesolimbic system responds to both pain and pleasure. In humans, bilateral activation of the amygdala has been reported to be associated with perceived pain intensity27 and has also consistently been reported in depression.28

Studies based on neuroimages have suggested an intimate relationship between regions in the brain associated with the emotional and sensory features of pain and regions affected by depression.29 Other neuroimaging findings indicate that patients with depression may demonstrate greater emotional reactivity than patients without depression, and that greater reactivity, in turn, may lead to a diminished ability to regulate pain.30 Further supporting the biologic overlap between the two disorders is evidence suggesting that pain and mood have comparable neuroanatomic substrates and neurobiologic mechanisms.31

NEUROPATHIC PAIN

Neuropathic pain is defined as a persistent pain syndrome caused by injury to the nervous system, including the dorsal root ganglion, dorsal root, peripheral nerve, or the central nervous system.32 The descending monoamine pathway, particularly serotonergic and noradrenergic transmission, is a crucial piece of the endogenous pain modulation system.33,34 Neuropathic pain can be considered a type of chronic stress that may share a common neuropathologic mechanism with stress-induced depression and consequently responds to similar treatments. Xu and colleagues demonstrated that using ferulic acid, a major active element in Angelica sinensis, effectively decreased chronic constriction injury–induced neuropathic pain via opioid receptors and the connection with the descending monoamine pathway.35 The study also found that the effects of ferulic acid on neuropathic pain are possibly moderated by amelioration of the descending monoamine pathway and the involvement of spinal 5-HT1A and beta-2 receptors.

The development of neuropathic pain stems from lesions of the central or peripheral somatosensory nervous system,36 although the location of the lesions is not consistent across individuals, as numerous nonphysical factors seem to influence and affect the development of neuropathic pain.37 Some of these factors include psychological components that have been increasingly studied and explored. Studies suggest that these psychological factors influence the perception of pain by affecting individual variations in the sensitivity to pain,38-40 as well as the progression of chronic pain.41-44 For example, catastrophizing and the anxiety that stems from pain negatively affect neuropathic pain and its management.45-49 The inclination to be preoccupied with pain-related somatic sensations (ie, pain vigilance) has also been linked to the development of chronic pain.50,51 Furthermore, positive psychological outlooks and attitudes such as optimism have been associated with a greater ability to cope with pain and a lower severity of pain.52-54 On the other hand, distress, anxiety, negative attitudes, and somatization have been associated with the development of chronic pain.55-58

Dispositional optimism is defined as an individual's general expectation of positive outcomes in various circumstances in life.53 Dispositional optimism has been demonstrated to be a positive predictor of health status following psychological trauma,59,60 in numerous clinical conditions,61-63 and in chronic pain.64-66 In fact, dispositional optimism has served as a protective factor, along with low emotional distress and positive affect, against developing neuropathic pain in patients following breast surgery.67

Neuropathic pain commonly does not respond to analgesics but is sensitive to a number of antidepressants, including amitriptyline, a tricyclic antidepressant; moclobemide, a reversible monoamine oxidase A inhibitor; and milnacipran and venlafaxine, serotonin-noradrenaline reuptake inhibitors.68 The complex relationship between depression and pain demonstrates that multitargeted therapy can aid in the management of neuropathic pain with enhanced efficacy compared to therapies that target single pathways.69 A number of herbal medicines have been used as psychiatric drugs as well,34,70,71 including curcumin and St. John's wort, and have shown similar efficacy in ameliorating depressive symptoms with fewer adverse side effects compared to prescription drugs.35

Experimental Inducibility of Neuropathic Pain

A study conducted by Lötsch et al demonstrated that for 60%-70% of 11 standardly analyzed Quantitative Sensory Testing (QST) parameters, clinical patterns similar to those of neuropathic pain could be mimicked in healthy volunteers following the application of topical capsaicin.72 However, only 18% of the participants in the Lötsch et al study demonstrated neuropathy-like symptoms, thereby posing the question, what factors contribute to this clinical presentation? Dimova et al conducted an observational study of healthy subjects who were assessed based on a set of psychological variables that make up pain-related cognitive-emotional and general psychological mechanisms.73 Dispositional optimism was quantified using the Life Orientation Test (LOT). Dimova et al found that LOT scores differed significantly between groups in which a neuropathy-like pattern of pain could or could not be partly induced, assessed via QST. Thus, they concluded that the likelihood of being able to induce the clinical presentation of neuropathic pain using topical capsaicin application depended on psychological factors, namely pessimistic disposition.

FACTORS AFFECTING THE RELATIONSHIP BETWEEN DEPRESSION AND PAIN

Opioid Use

The use of opioids for the management of chronic and acute pain has increased dramatically. In fact, from 1997 to 2005, hydrocodone prescriptions increased 198%, oxycodone prescriptions increased 588%, and methadone prescriptions increased 933%.74 In 2014, more than 10 million Americans aged 12 years and older used opioid analgesics nonmedically.75 Although opioids can be used effectively for short-term management of cancer pain and acute pain,76 a paucity of evidence supports the administration of opioids for long-term management of chronic noncancer pain.77-80 Because of the risk of addiction and unfavorable side effects, opioids should only be used continuously when the benefit to the patient is very clear. For instance, continuing opioid treatment is advisable if the patient shows clear improvement across multiple domains including better quality of life, decreased pain, and improved functioning.81 Commonly, patients find that after prolonged use, opioids are ineffective in reducing pain, and dosing needs to be steadily increased. Understanding that many patients increase their doses rather than discontinuing a medication that no longer effectively controls their pain, making clinical decisions regarding the maintenance of an opioid regimen in patients suffering from chronic pain can be difficult.81

Because patients with psychiatric diagnoses are commonly excluded from efficacy trials with opioids,82 assessment of the safety and efficacy of opioid use in patients with chronic pain and mental health diagnoses remains fairly unexplored. Some studies have suggested that the prototypical patient who is prescribed opioids in clinical practice contrasts with patients selected to participate in clinical trials, thereby muddling the data. For example, numerous studies have demonstrated that patients with depression are more likely to be given opioids and in higher doses than patients without depression in various settings, including the emergency department and primary care offices.83-85 Howe and Sullivan have proposed that this finding may be a contributing factor to the adverse usage of opioids.86

The link between the use of opioids and depression is likely multifactorial and complicated. Accordingly, there are numerous modes of thought regarding their relationship, including one that argues that patients with depression experience more severe pain compared to patients without depression, thus requiring higher doses of opioids and increasing the likelihood of having opioids prescribed.87 Howe and Sullivan have proposed that patients with mental health comorbidities are prescribed opioids more frequently, a process referred to as adverse selection.86 A study by Edlund et al showed that patients with mental health disorders are more at risk for developing an addiction to opioids.88 Sullivan et al believe that the added burden of emotional pain experienced by patients with mental health disorders affects the individual's and the healthcare provider's discernment of distress, resulting in the initiation of opioids to manage both physical and emotional pain.89

Goesling and colleagues investigated the relationship between depression, opioid use, and pain in patients at a university-based outpatient pain clinic, and their findings support the idea that the presence of depression may favor the initiation and continuation of opioid administration.81 Of the 2,104 patients who participated, 55.89% were using opioids at the time of the study. Compared to the nonopioid users in the study, the opioid-using subjects reported a worse phenotypic profile: worse physical functioning and greater severity of pain. Furthermore, a greater portion of opioid users reported depressive symptoms compared to those not taking opioids (43.6% vs 26.8%, P<0.001). Pain severity was linked with a greater likelihood of taking opioids, but this finding was moderated by depression. Among patients without depression, the researchers reported a positive correlation between the predicted probabilities of using opioids as pain severity increased, but this probability was not dependent on pain severity in the patients with symptoms of depression.

The findings of the Goesling et al study81 have important implications for the reevaluation of continued opioid use in patients with chronic pain, particularly when evidence suggests that opioids do not adequately control chronic pain.77-79 Goesling et al argue that although selection bias can explain higher rates of depression among the clinical population that is already taking opioids compared to the population not on opioids, another possibility worth considering is that longitudinal usage of opioids may propagate or worsen depression. A longitudinal study conducted in a nonmedical prescription opioid population found that worsening depression was associated with greater mean daily doses of opioids.90 Another study based on a cohort of patients with low back pain found that a greater daily dose of opioids led to a greater risk for new-onset depression.91

Scherrer et al conducted a retrospective study of two large patient cohorts with substantial differences in comorbidity burdens and demographics.92 They observed that in both groups, subjects who were in remission from depression had a roughly 2-fold increased risk of depression recurrence if they had started opioid therapy relative to those who had not. The authors suggest that a possible explanation for this finding is that opioid use may counteract complete remission and increase the chances of recurrent depression. Given the lack of clarity regarding the relationship between chronic opioid use and depression, additional studies must be conducted to assess this relationship.

Positive Psychological Factors

An increasing number of studies recognize the positive psychological factors that affect how individuals adjust to persistent pain, including hope, pain acceptance, and optimism.93-96

Snyder et al define hope as a mental belief in one's ability to initiate and propagate actions and the belief in one's ability to initiate pathways to attain goals.97 Hope has been associated with decreased pain and symptoms in patients with chronic diseases including multiple sclerosis98 and cancer.93,99 Hope has also been linked to decreased functional disability, distress, and physical weakening in patients with pain secondary to traumatic injuries.100-102

Pain acceptance is defined as accepting what cannot be altered, getting involved in meaningful activities despite the pain, and decreasing ineffective endeavors to eliminate pain.103,104 The literature suggests that subjects with higher levels of pain acceptance experience substantially lower levels of pain, pain-associated disability, and distress.105-107

Gender

Research has begun to explore and support findings of gender differences in relation to pain, including differences in effectiveness of analgesia, vulnerability to diseases associated with pain, and recovery from anesthesia.108-110 In studies of experimentally induced pain, women have demonstrated lower tolerance for and diminished thresholds to a broad assortment of noxious stimuli relative to men.111,112 In addition, epidemiologic studies suggest that women report more negative responses to pain and more numerous pain experiences than men.113,114 A number of studies115-117 have attributed the gender differences in pain experiences to biologic differences, although the argument supporting psychological and social factors has also grown considerably.

A study by Ramírez-Maestre and Esteve of 400 patients with chronic spinal pain attending primary care units found that women scored considerably higher than men on pain intensity and pain anxiety.118 In regards to chronic pain, a higher report of pain intensity has been considered an indication of maladjustment to chronic pain.118 However, in an earlier study, the authors suggest that the level of daily functioning may serve as a more accurate indicator of adjustment and capacity in patients who report pain.119

Gender roles have had an impact on reports of pain intensity because of female gender norms being structured so that the expression of pain is more acceptable in females than in males and a routine part of life, whereas male gender norms demand greater tolerance to pain compared to females.111,115,116 Therefore, Ramírez-Maestre and Esteve concluded that although men in their study reported lower levels of pain intensity and pain anxiety relative to women, the women demonstrated greater adaptation to chronic pain as indicated by their levels of functioning and levels of anxiety and depression compared to the men in the study.118

Acute Postoperative Pain

The relationship between psychological morbidity and acute postoperative pain is largely unexplored and requires investigation. Despite advancements in pain management, patients continue to report moderate to severe pain postoperatively. Severe pain has been associated with prolonged postoperative recovery-to-ambulation time; progression to chronic postoperative pain; lower patient satisfaction; and greater mortality, morbidity, and risk of cardiac and pulmonary complications.120,121 Taenzer et al demonstrated that patients with depression prior to surgery had significantly greater analgesic requirements and postoperative pain compared to patients without depression.122 Consistent with these findings, De Cosmo et al found that subjects with depression and preoperative anxiety consumed greater amounts of tramadol and postoperatively reported greater pain intensities compared to subjects without depression.123

Royse et al found that adequate postoperative analgesia administration may be a factor in postoperative depression.124 They compared the outcomes of patients receiving high thoracic epidural analgesics to those of patients who received patient-controlled intravenous analgesics for 3 days after coronary artery bypass surgery. Patients who received high thoracic epidural analgesia reported better pain relief and had a lower likelihood of developing depression compared to those on patient-controlled analgesics.

CONCLUSION

The relationship between pain and psychology is complex and multifactorial. The intricate relationship between the two processes is evidenced by the clinical overlap in their presentations and the overlap between the anatomic regions in the brain associated with the emotional and sensory features of pain and the areas affected by depression. Studies are beginning to improve our understanding of these two systems, but more studies are needed to elucidate the relationship with the goal of optimizing treatment for patients with depression and concurrent chronic pain and thereby reducing hospital stay and healthcare costs.

This article meets the Accreditation Council for Graduate Medical Education and the American Board of Medical Specialties Maintenance of Certification competencies for Patient Care and Medical Knowledge.

ACKNOWLEDGMENTS

The authors have no financial or proprietary interest in the subject matter of this article.

REFERENCES

  1. 1
    ↵
    LépineJP, BrileyM. The epidemiology of pain in depression. Hum Psychopharmacol. 2004 10; 19 Suppl 1: S3- S7. 15378670
    Google ScholarCrossRefPubMedWeb of Science
  2. 2
    ↵
    Agüera-OrtizL, FaildeI, MicoJA, CervillaJ, López-IborJJ. Pain as a symptom of depression: prevalence and clinical correlates in patients attending psychiatric clinics. J Affect Disord. 2011 4; 130 1-2: 106- 112. doi: 10.1016/j.jad.2010.10.022. 21055826
    CrossRefPubMed
  3. 3
    ↵
    BairMJ, RobinsonRL, KatonW, KroenkeK. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003 11 10; 163 20: 2433- 2445. 14609780
    Google ScholarCrossRefPubMedWeb of Science
  4. 4
    ↵
    GaskinDJ, RichardP. The economic costs of pain in the United States. J Pain. 2012 8; 13 8: 715- 724. doi: 10.1016/j.jpain.2012.03.009. 22607834
    CrossRefPubMedWeb of Science
  5. 5
    ↵
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association; 1994: 143- 147.
    Google Scholar
  6. 6
    ↵
    DemyttenaereK, BruffaertsR, LeeS, Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain. 2007 6; 129 3: 332- 342. 17350169
    Google ScholarCrossRefPubMedWeb of Science
  7. 7
    ↵
    OhayonMM, SchatzbergAF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry. 2003 1; 60 1: 39- 47. 12511171
    Google ScholarCrossRefPubMedWeb of Science
  8. 8
    ↵
    OhayonMM. Specific characteristics of the pain/depression association in the general population. J Clin Psychiatry. 2004; 65 Suppl 12: 5- 9.
    Google Scholar
  9. 9
    ↵
    BrechtS, CourtecuisseC, DebieuvreC, Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial. J Clin Psychiatry. 2007 11; 68 11: 1707- 1716. 18052564
    Google ScholarCrossRefPubMedWeb of Science
  10. 10
    GieseckeT, GracelyRH, WilliamsDA, GeisserME, PetzkeFW, ClauwDJ. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005 5; 52 5: 1577- 1584. 15880832
    Google ScholarCrossRefPubMedWeb of Science
  11. 11
    ↵
    LeeP, ZhangM, HongJP, Frequency of painful physical symptoms with major depressive disorder in Asia: relationship with disease severity and quality of life. J Clin Psychiatry. 2009 1; 70 1: 83- 91. 19192462
    Google ScholarCrossRefPubMedWeb of Science
  12. 12
    ↵
    KesslerRC, BerglundP, DemlerO, National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003 6 18; 289 23: 3095- 3105. 12813115
    Google ScholarCrossRefPubMedWeb of Science
  13. 13
    ↵
    BairMJ, RobinsonRL, EckertGJ, StangPE, CroghanTW, KroenkeK. Impact of pain on depression treatment response in primary care. Psychosom Med. 2004 Jan-Feb; 66 1: 17- 22. 14747633
    Google ScholarCrossRefAbstract/Full TextPubMedWeb of Science
  14. 14
    ↵
    BaoY, SturmR, CroghanTW. A national study of the effect of chronic pain on the use of health care by depressed persons. Psychiatr Serv. 2003 5; 54 5: 693- 697. 12719500
    Google ScholarCrossRefPubMedWeb of Science
  15. 15
    ↵
    KarpJF, ScottJ, HouckP, ReynoldsCF3rd, KupferDJ, FrankE. Pain predicts longer time to remission during treatment of recurrent depression. J Clin Psychiatry. 2005 5; 66 5: 591- 597. 15889945
    Google ScholarCrossRefPubMedWeb of Science
  16. 16
    ↵
    MillerLR, CanoA. Comorbid chronic pain and depression: who is at risk? J Pain. 2009 6; 10 6: 619- 627. doi: 10.1016/j.jpain.2008.12.007. 19398383
    CrossRefPubMedWeb of Science
  17. 17
    ↵
    OhayonMM, SchatzbergAF. Chronic pain and major depressive disorder in the general population. J Psychiatr Res. 2010 5; 44 7: 454- 461. doi: 10.1016/j.jpsychires.2009.10.013. 20149391
    CrossRefPubMed
  18. 18
    ↵
    WiechK, TraceyI. The influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage. 2009 9; 47 3: 987- 994. doi: 10.1016/j.neuroimage.2009.05.059. 19481610
    CrossRefPubMedWeb of Science
  19. 19
    ↵
    RhudyJL, MeagherMW. Fear and anxiety: divergent effects on human pain thresholds. Pain. 2000 1; 84 1: 65- 75. 10601674
    Google ScholarCrossRefPubMedWeb of Science
  20. 20
    ↵
    RhudyJL, MeagherMW. Individual differences in the emotional reaction to shock determine whether hypoalgesia is observed. Pain Med. 2003 9; 4 3: 244- 256. 12974824
    Google ScholarCrossRefPubMed
  21. 21
    ↵
    RhudyJL, WilliamsAE. Gender differences in pain: do emotions play a role? Gend Med. 2005 12; 2 4: 208- 226. 16464733
    Google ScholarCrossRefPubMed
  22. 22
    ↵
    MartensonME, CetasJS, HeinricherMM. A possible neural basis for stress-induced hyperalgesia. Pain. 2009 4; 142 3: 236- 244. 19232470
    Google ScholarCrossRefPubMedWeb of Science
  23. 23
    ↵
    Von KorffM, SimonG. The relationship between pain and depression. Br J Psychiatry Suppl. 1996 6; (30):101-108.
    Google Scholar
  24. 24
    ↵
    StahlS, BrileyM. Understanding pain in depression. Hum Psychopharmacol. 2004 10; 19 Suppl 1: S9- S13. 15378669
    Google ScholarCrossRefPubMedWeb of Science
  25. 25
    ↵
    MaybergHS. Defining the neural circuitry of depression: toward a new nosology with therapeutic implications. Biol Psychiatry. 2007 3 15; 61 6: 729- 730. 17338903
    Google ScholarCrossRefPubMedWeb of Science
  26. 26
    ↵
    BerridgeK, WinkielmanP. What is an unconscious emotion? (The case for unconscious “liking”). Cogn Emot. 2003; 17 2: 181- 211. doi: 10.1080/02699930302289.
    CrossRef
  27. 27
    ↵
    BornhövdK, QuanteM, GlaucheV, BrommB, WeillerC, BüchelC. Painful stimuli evoke different stimulus–response functions in the amygdala, prefrontal, insula and somatosensory cortex: a single-trial fMRI study. Brain. 2002 6; 125 Pt 6: 1326- 1336. 12023321
    Google ScholarCrossRefPubMedWeb of Science
  28. 28
    ↵
    ShelineYI. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry. 2003 8 1; 54 3: 338- 352. 12893109
    Google ScholarCrossRefPubMedWeb of Science
  29. 29
    ↵
    EhnvallA, MitchellPB, Hadzi-PavlovicD, MalhiGS, ParkerG. Pain during depression and relationship to rejection sensitivity. Acta Psychiatr Scand. 2009 5; 119 5: 375- 382. doi: 10.1111/j.1600-0447.2008.01316.x. 19076116
    CrossRefPubMed
  30. 30
    ↵
    StrigoIA, SimmonsAN, MatthewsSC, CraigAD, PaulusMP. Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain. Arch Gen Psychiatry. 2008 11; 65 11: 1275- 1284. doi: 10.1001/archpsyc.65.11.1275. 18981339
    CrossRefPubMedWeb of Science
  31. 31
    ↵
    MicóJA, ArdidD, BerrocosoE, EschalierA. Antidepressants and pain. Trends Pharmacol Sci. 2006 7; 27 7: 348- 354. 16762426
    Google ScholarCrossRefPubMedWeb of Science
  32. 32
    ↵
    WoolfCJ, MannionRJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999 6 5; 353 9168: 1959- 1964. 10371588
    Google ScholarCrossRefPubMedWeb of Science
  33. 33
    ↵
    ChaplanSR, BachFW, PogrelJW, ChungJM, YakshTL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994 7; 53 1: 55- 63. 7990513
    Google ScholarCrossRefPubMedWeb of Science
  34. 34
    ↵
    ZhaoX, WangC, ZhangJF, Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor. Psychopharmacology (Berl). 2014 5; 231 10: 2171- 2187. doi: 10.1007/s00213-013-3368-2. 24297305
    CrossRefPubMed
  35. 35
    ↵
    XuY, LinD, YuX, The antinociceptive effects of ferulic acid on neuropathic pain: involvement of descending monoaminergic system and opioid receptors. Oncotarget. 2016 4 12; 7 15: 20455- 20468. doi: 10.18632/oncotarget.7973. 26967251
    CrossRefPubMed
  36. 36
    ↵
    BaronR, BinderA, WasnerG. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010 8; 9 8: 807- 819. doi: 10.1016/S1474-4422(10)70143-5. 20650402
    CrossRefPubMedWeb of Science
  37. 37
    ↵
    von HehnCA, BaronR, WoolfCJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron. 2012 2 23; 73 4: 638- 652. doi: 10.1016/j.neuron.2012.02.008. 22365541
    CrossRefPubMedWeb of Science
  38. 38
    ↵
    GeorgeSZ, HirshAT. Psychologic influence on experimental pain sensitivity and clinical pain intensity for patients with shoulder pain. J Pain. 2009 3; 10 3: 293- 299. doi: 10.1016/j.jpain.2008.09.004. 19070551
    CrossRefPubMedWeb of Science
  39. 39
    HanssenMM, VancleefLM, VlaeyenJW, PetersML. More optimism, less pain! The influence of generalized and pain-specific expectations on experienced cold-pressor pain. J Behav Med. 2014 2; 37 1: 47- 58. doi: 10.1007/s10865-012-9463-8. 23239369
    CrossRefPubMed
  40. 40
    ↵
    HirshAT, GeorgeSZ, BialoskyJE, RobinsonME. Fear of pain, pain catastrophizing, and acute pain perception: relative prediction and timing of assessment. J Pain. 2008 9; 9 9: 806- 812. doi: 10.1016/j.jpain.2008.03.012. 18486557
    CrossRefPubMed
  41. 41
    ↵
    KeoghE, Book K, Thomas J, Giddins G, Eccleston C. Predicting pain and disability in patients with hand fractures: comparing pain anxiety, anxiety sensitivity and pain catastrophizing. Eur J Pain. 2010 4; 14 4: 446- 451. doi: 10.1016/j.ejpain.2009.08.001. 19729326
    CrossRefPubMed
  42. 42
    LautenbacherS, HuberC, SchöferD, Attentional and emotional mechanisms related to pain as predictors of chronic postoperative pain: a comparison with other psychological and physiological predictors. Pain. 2010 12; 151 3: 722- 731. doi: 10.1016/j.pain.2010.08.041. 20850220
    CrossRefPubMedWeb of Science
  43. 43
    PetersML, SommerM, van KleefM, MarcusMA. Predictors of physical and emotional recovery 6 and 12 months after surgery. Br J Surg. 2010 10; 97 10: 1518- 1527. doi: 10.1002/bjs.7152. 20737463
    CrossRefPubMed
  44. 44
    ↵
    PincusT, BurtonAK, VogelS, FieldAP. A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain. Spine (Phila Pa 1976). 2002 3 1; 27 5: E109- E120. 11880847
    Google ScholarCrossRefPubMed
  45. 45
    ↵
    MankovskyT, LynchM, ClarkA, SawynokJ, SullivanMJ. Pain catastrophizing predicts poor response to topical analgesics in patients with neuropathic pain. Pain Res Manag. 2012 Jan-Feb; 17 1: 10- 14. 22518362
    Google ScholarPubMed
  46. 46
    PhillipsTJ, BrownM, RamirezJD, Sensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: a cross-sectional deep profiling study. Pain. 2014 9; 155 9: 1846- 1860. doi: 10.1016/j.pain.2014.06.014. 24973717
    CrossRefPubMed
  47. 47
    SchlerethT, HeilandA, BreimhorstM, Association between pain, central sensitization and anxiety in postherpetic neuralgia. Eur J Pain. 2015 2; 19 2: 193- 201. doi: 10.1002/ejp.537. 25070366
    CrossRefPubMed
  48. 48
    SelvarajahD, CashT, SankarA, The contributors of emotional distress in painful diabetic neuropathy. Diab Vasc Dis Res. 2014 7; 11 4: 218- 225. 24821753
    Google ScholarCrossRefPubMed
  49. 49
    ↵
    TothC, BradyS, HatfieldM. The importance of catastrophizing for successful pharmacological treatment of peripheral neuropathic pain. J Pain Res. 2014 6 24; 7: 327- 338. doi: 10.2147/JPR.S56883. 25028563
    CrossRefPubMed
  50. 50
    ↵
    LautenbacherS, HuberC, BaumC, RossaintR, HochreinS, HeesenM. Attentional avoidance of negative experiences as predictor of postoperative pain ratings and consumption of analgesics: comparison with other psychological predictors. Pain Med. 2011 4; 12 4: 645- 653. doi: 10.1111/j.1526-4637.2011.01076.x. 21392251
    CrossRefPubMed
  51. 51
    ↵
    LautenbacherS, HuberC, KunzM, Hypervigilance as predictor of postoperative acute pain: its predictive potency compared with experimental pain sensitivity, cortisol reactivity, and affective state. Clin J Pain. 2009 2; 25 2: 92- 100. doi: 10.1097/AJP.0b013e3181850dce. 19333152
    CrossRefPubMedWeb of Science
  52. 52
    ↵
    BoselieJJ, VancleefLM, SmeetsT, PetersML. Increasing optimism abolishes pain-induced impairments in executive task performance. Pain. 2014 2; 155 2: 334- 340. doi: 10.1016/j.pain.2013.10.014. 24145210
    CrossRefPubMed
  53. 53
    ↵
    GoodinBR, BullsHW. Optimism and the experience of pain: benefits of seeing the glass as half full. Curr Pain Headache Rep. 2013 5; 17 5: 329 doi: 10.1007/s11916-013-0329-8. 23519832
    CrossRefPubMed
  54. 54
    ↵
    GoodinBR, GloverTL, SotolongoA, The association of greater dispositional optimism with less endogenous pain facilitation is indirectly transmitted through lower levels of pain catastrophizing. J Pain. 2013 2; 14 2: 126- 135. doi: 10.1016/j.jpain.2012.10.007. 23218934
    CrossRefPubMed
  55. 55
    ↵
    DiatchenkoL, FillingimRB, SmithSB, MaixnerW. The phenotypic and genetic signatures of common musculoskeletal pain conditions. Nat Rev Rheumatol. 2013 6; 9 6: 340- 350. doi: 10.1038/nrrheum.2013.43. 23545734
    CrossRefPubMed
  56. 56
    FinanPH, QuartanaPJ, SmithMT. Positive and negative affect dimensions in chronic knee osteoarthritis: effects on clinical and laboratory pain. Psychosom Med. 2013 6; 75 5: 463- 470. doi: 10.1097/PSY.0b013e31828ef1d6. 23697467
    CrossRefAbstract/Full TextPubMed
  57. 57
    Shedden Mora M, Weber D, Borkowski S, Rief W. Nocturnal masseter muscle activity is related to symptoms and somatization in temporomandibular disorders. J Psychosom Res. 2012 10; 73 4: 307- 312. doi: 10.1016/j.jpsychores.2012.07.008. 22980538
    CrossRefPubMed
  58. 58
    ↵
    SullivanMJ, ThornB, RodgersW, WardLC. Path model of psychological antecedents to pain experience: experimental and clinical findings. Clin J Pain. 2004 May-Jun; 20 3: 164- 173. 15100592
    Google ScholarCrossRefPubMedWeb of Science
  59. 59
    ↵
    IacovielloBM, CharneyDS. Psychosocial facets of resilience: implications for preventing posttrauma psychopathology, treating trauma survivors, and enhancing community resilience. Eur J Psychotraumatol. 2014 Oct 1;5. doi: 10.3402/ejpt.v5.23970.
  60. 60
    ↵
    SegoviaF, MooreJL, LinnvilleSE, HoytRE, HainRE. Optimism predicts resilience in repatriated prisoners of war: a 37-year longitudinal study. J Trauma Stress. 2012 6; 25 3: 330- 336. doi: 10.1002/jts.21691. 22615194
    CrossRefPubMedWeb of Science
  61. 61
    ↵
    BeitelM, SavantJD, CutterCJ, PetersS, BelisleN, BarryDT. Psychopathology and pain correlates of dispositional optimism in methadone-maintained patients. Am J Addict. 2012 11; 21 Suppl 1: S56- S62. doi: 10.1111/j.1521-0391.2012.00293.x. 23786512
    CrossRefPubMed
  62. 62
    GisonA, Dall'ArmiV, DonatiV, RizzaF, GiaquintoS. Dispositional optimism, depression, disability and quality of life in Parkinson's disease. Funct Neurol. 2014 Apr-Jun; 29 2: 113- 119. 25306121
    Google ScholarCrossRefPubMed
  63. 63
    ↵
    VassendO, QualeAJ, RøiseO, SchankeAK. Predicting the long-term impact of acquired severe injuries on functional health status: the role of optimism, emotional distress and pain. Spinal Cord. 2011 12; 49 12: 1193- 1197. doi: 10.1038/sc.2011.70. 21691279
    CrossRefPubMed
  64. 64
    ↵
    Cruz-AlmeidaY, KingCD, GoodinBR, Psychological profiles and pain characteristics of older adults with knee osteoarthritis. Arthritis Care Res (Hoboken). 2013 11; 65 11: 1786- 1794. 23861288
    Google ScholarPubMed
  65. 65
    HoofwijkDM, FiddelersAA, PetersML, Prevalence and predictive factors of chronic postsurgical pain and poor global recovery 1 year after outpatient surgery. Clin J Pain. 2015 12; 31 12: 1017- 1025. doi: 10.1097/AJP.0000000000000207. 25565589
    CrossRefPubMed
  66. 66
    ↵
    Ramírez-MaestreC, EsteveR. Disposition and adjustment to chronic pain. Curr Pain Headache Rep. 2013 3; 17 3: 312 doi: 10.1007/s11916-012-0312-9. 23338768
    CrossRefPubMed
  67. 67
    ↵
    BruceJ, ThorntonAJ, PowellR, Recovery Study Group. Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain. 2014 2; 155 2: 232- 243. doi: 10.1016/j.pain.2013.09.028. 24099954
    CrossRefPubMed
  68. 68
    ↵
    VillarinhoJG, PinheiroKde V, PinheiroFde V, The antinociceptive effect of reversible monoamine oxidase-A inhibitors in a mouse neuropathic pain model. Prog Neuropsychopharmacol Biol Psychiatry. 2013 7 1; 44: 136- 142. doi: 10.1016/j.pnpbp.2013.02.005. 23419243
    CrossRefPubMed
  69. 69
    ↵
    XuY, ZhangL, ShaoT, Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses. Metab Brain Dis. 2013 12; 28 4: 571- 583. doi: 10.1007/s11011-013-9404-4. 23584961
    CrossRefPubMed
  70. 70
    ↵
    ChiappediM, BejorM. Herbals and natural dietary supplements in psychiatric practice. Recent Pat CNS Drug Discov. 2010 6; 5 2: 164- 171. 20030623
    Google ScholarPubMed
  71. 71
    ↵
    XuY, KuBS, YaoHY, The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol. 2005 7 25; 518 1: 40- 46. 15987635
    Google ScholarCrossRefPubMed
  72. 72
    ↵
    LötschJ, DimovaV, HermensH, Pattern of neuropathic pain induced by topical capsaicin application in healthy subjects. Pain. 2015 3; 156 3: 405- 414. doi: 10.1097/01.j.pain.0000460328.10515.c9. 25687540
    CrossRefPubMed
  73. 73
    ↵
    DimovaV, OertelBG, KabakciG, A more pessimistic life orientation is associated with experimental inducibility of a neuropathy-like pain pattern in healthy individuals. J Pain. 2015 8; 16 8: 791- 800. doi: 10.1016/j.jpain.2015.05.004. 26056011
    CrossRefPubMed
  74. 74
    ↵
    ManchikantiL. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician. 2007 3; 10 3: 399- 424. 17525776
    Google ScholarPubMed
  75. 75
    ↵
    PezallaEJ, RosenD, ErensenJG, HaddoxJD, MayneTJ. Secular trends in opioid prescribing in the USA. J Pain Res. 2017 2; 10: 383- 387. doi: 10.2147/JPR.S129553. 28243142
    CrossRefPubMed
  76. 76
    ↵
    ChouR, FanciulloGJ, FinePG, American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009 2; 10 2: 113- 130. doi: 10.1016/j.jpain.2008.10.008. 19187889
    CrossRefPubMedWeb of Science
  77. 77
    ↵
    BallantyneJC. Opioids for chronic pain: taking stock. Pain. 2006 11; 125 1-2: 3- 4. 16934403
    Google ScholarCrossRefPubMedWeb of Science
  78. 78
    BallantyneJC, ShinNS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008 Jul-Aug; 24 6: 469- 478. doi: 10.1097/AJP.0b013e31816b2f26. 18574357
    CrossRefPubMedWeb of Science
  79. 79
    ↵
    ChaparroLE, FurlanAD, DeshpandeA, Mailis-GagnonA, AtlasS, TurkDC. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev. 2013 Aug 27;(8):CD004959. doi: 10.1002/14651858.CD004959.pub4.
  80. 80
    ↵
    FurlanAD, SandovalJA, Mailis-GagnonA, TunksE. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006 5 23; 174 11: 1589- 1594. 16717269
    Google ScholarCrossRefAbstract/Full TextPubMed
  81. 81
    ↵
    GoeslingJ, HenryMJ, MoserSE, Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. J Pain. 2015 9; 16 9: 844- 851. doi: 10.1016/j.jpain.2015.05.010. 26080041
    CrossRefPubMed
  82. 82
    ↵
    KalsoE, EdwardsJE, MooreRA, McQuayHJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004 12; 112 3: 372- 380. 15561393
    Google ScholarCrossRefPubMedWeb of Science
  83. 83
    ↵
    EdlundMJ, MartinBC, DevriesA, FanMY, BradenJB, SullivanMD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010 1; 26 1: 1- 8. doi: 10.1097/AJP.0b013e3181b99f35. 20026946
    CrossRefPubMedWeb of Science
  84. 84
    SealKH, ShiY, CohenG, Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012 3 7; 307 9: 940- 947. doi: 10.1001/jama.2012.234. 22396516
    CrossRefPubMedWeb of Science
  85. 85
    ↵
    SullivanMD, EdlundMJ, SteffickD, UnützerJ. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005 12 15; 119 1-3: 95- 103. 16298066
    Google ScholarCrossRefPubMedWeb of Science
  86. 86
    ↵
    HoweCQ, SullivanMD. The missing ‘P' in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care. Gen Hosp Psychiatry. 2014 Jan-Feb; 36 1: 99- 104. doi: 10.1016/j.genhosppsych.2013.10.003. 24211157
    CrossRefPubMed
  87. 87
    ↵
    BörsboB, PeolssonM, GerdleB. The complex interplay between pain intensity, depression, anxiety and catastrophising with respect to quality of life and disability. Disabil Rehabil. 2009; 31 19: 1605- 1613. 19848559
    Google ScholarCrossRefPubMed
  88. 88
    ↵
    EdlundMJ, SteffickD, HudsonT, HarrisKM, SullivanM. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007 6; 129 3: 355- 362. 17449178
    Google ScholarCrossRefPubMedWeb of Science
  89. 89
    ↵
    SullivanMD, EdlundMJ, ZhangL, UnützerJ, WellsKB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006 10 23; 166 19: 2087- 2093. 17060538
    Google ScholarCrossRefPubMedWeb of Science
  90. 90
    ↵
    MartinsSS, FentonMC, KeyesKM, BlancoC, ZhuH, StorrCL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2012 6; 42 6: 1261- 1272. doi: 10.1017/S0033291711002145. 21999943
    CrossRefPubMed
  91. 91
    ↵
    ScherrerJF, SalasJ, LustmanPJ, BurgeS, SchneiderFD; Residency Research Network of Texas (RRNeT) Investigators. Change in opioid dose and change in depression in a longitudinal primary care patient cohort. Pain. 2015 2; 156 2: 348- 355. doi: 10.1097/01.j.pain.0000460316.58110.a0. 25599457
    CrossRefPubMed
  92. 92
    ↵
    ScherrerJF, SalasJ, CopelandLA, Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain. 2016 4; 17 4: 473- 482. doi: 10.1016/j.jpain.2015.12.012. 26884282
    CrossRefPubMed
  93. 93
    ↵
    BerendesD, KeefeFJ, SomersTJ, KothadiaSM, PorterLS, CheavensJS. Hope in the context of lung cancer: relationships of hope to symptoms and psychological distress. J Pain Symptom Manage. 2010 8; 40 2: 174- 182. doi: 10.1016/j.jpainsymman.2010.01.014. 20579840
    CrossRefPubMedWeb of Science
  94. 94
    ElanderJ, RobinsonG, MitchellK, MorrisJ. An assessment of the relative influence of pain coping, negative thoughts about pain, and pain acceptance on health-related quality of life among people with hemophilia. Pain. 2009 9; 145 1-2: 169- 175. doi: 10.1016/j.pain.2009.06.004. 19573989
    CrossRefPubMedWeb of Science
  95. 95
    FerreiraVM, ShermanAM. The relationship of optimism, pain and social support to well-being in older adults with osteoarthritis. Aging Ment Health. 2007 1; 11 1: 89- 98. 17164163
    Google ScholarCrossRefPubMedWeb of Science
  96. 96
    ↵
    GauthierLR, RodinG, ZimmermannC, Acceptance of pain: a study in patients with advanced cancer. Pain. 2009 5; 143 1-2: 147- 154. doi: 10.1016/j.pain.2009.02.009. 19321264
    CrossRefPubMedWeb of Science
  97. 97
    ↵
    SnyderCR, HarrisC, AndersonJR, The will and the ways: development and validation of an individual-differences measure of hope. J Pers Soc Psychol. 1991 4; 60 4: 570- 585. 2037968
    Google ScholarCrossRefPubMedWeb of Science
  98. 98
    ↵
    TreeHA. Multiple sclerosis severity, pain intensity, and psychosocial factors: Associations with perceived social support, hope, optimism, depression, and fatigue. 2009 http://search.proquest.com/docview/304917622. Accessed April 12, 2017.
  99. 99
    ↵
    StantonAL, Danoff-BurgS, CameronCL, Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. J Consult Clin Psychol. 2000 10; 68 5: 875- 882. 11068973
    Google ScholarCrossRefPubMedWeb of Science
  100. 100
    ↵
    CreamerM, O'DonnellML, CarboonI, Evaluation of the Dispositional Hope Scale in injury survivors. J Res Pers. 2009 8; 43 4: 613- 617. doi: 10.1016/j.jrp.2009.03.002.
    CrossRef
  101. 101
    ElliottTR, WittyTE, HerrickS, HoffmanJT. Negotiating reality after physical loss: hope, depression, and disability. J Pers Soc Psychol. 1991 10; 61 4: 608- 613. 1835735
    Google ScholarCrossRefPubMedWeb of Science
  102. 102
    ↵
    PelegG, BarakO, HarelY, RochbergJ, HoofienD. Hope, dispositional optimism and severity of depression following traumatic brain injury. Brain Inj. 2009 9; 23 10: 800- 808. doi: 10.1080/02699050903196696. 19697168
    CrossRefPubMed
  103. 103
    ↵
    FormanEM, ButrynML, HoffmanKL, HerbertJD. An open trial of an acceptance-based behavioral intervention for weight loss. Cogn Behav Pract. 2009 5; 16 2: 223- 235. doi: 10.1016/j.cbpra.2008.09.005.
    CrossRefWeb of Science
  104. 104
    ↵
    McCrackenLM, VowlesKE, EcclestonC. Acceptance of chronic pain: component analysis and a revised assessment method. Pain. 2004 1; 107 1-2: 159- 166. 14715402
    Google ScholarCrossRefPubMedWeb of Science
  105. 105
    ↵
    McCrackenLM. Learning to live with the pain: acceptance of pain predicts adjustment in persons with chronic pain. Pain. 1998 1; 74 1: 21- 27. 9514556
    Google ScholarCrossRefPubMedWeb of Science
  106. 106
    McCrackenLM, VowlesKE, EcclestonC. Acceptance-based treatment for persons with complex, long standing chronic pain: a preliminary analysis of treatment outcome in comparison to a waiting phase. Behav Res Ther. 2005 10; 43 10: 1335- 1346. 16086984
    Google ScholarCrossRefPubMedWeb of Science
  107. 107
    ↵
    VianeI, CrombezG, EcclestonC, Acceptance of pain is an independent predictor of mental well-being in patients with chronic pain: empirical evidence and reappraisal. Pain. 2003 11; 106 1-2: 65- 72. 14581112
    Google ScholarCrossRefPubMedWeb of Science
  108. 108
    ↵
    CicconeGK, HoldcroftA. Drugs and sex differences: a review of drugs relating to anaesthesia. Br J Anaesth. 1999 2; 82 2: 255- 265. 10365004
    Google ScholarCrossRefPubMed
  109. 109
    FillingimRB, NessTJ. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev. 2000 6; 24 4: 485- 501. 10817845
    Google ScholarCrossRefPubMedWeb of Science
  110. 110
    ↵
    MylesPS, McLeodAD, HuntJO, FletcherH. Sex differences in speed of emergence and quality of recovery after anaesthesia: cohort study. BMJ. 2001 3 24; 322 7288: 710- 711. 11264210
    Google ScholarCrossRefFull TextPubMedWeb of Science
  111. 111
    ↵
    AlabasOA, TashaniOA, TabasamG, JohnsonMI. Gender role affects experimental pain responses: a systematic review with meta-analysis. Eur J Pain. 2012 10; 16 9: 1211- 1223. doi: 10.1002/j.1532-2149.2012.00121.x. 22434689
    CrossRefPubMed
  112. 112
    ↵
    FillingimRB, MaixnerW. Gender differences in the responses to noxious stimuli. Pain Forum. 1995 Winter; 4 4: 209- 221. doi: 10.1016/S1082-3174(11)80022-X.
    CrossRefWeb of Science
  113. 113
    ↵
    HoldcroftA, BerkleyKJ. Sex and gender differences in pain and its relief. : McMahonS, KoltzenburgM, Wall and Melzack's Textbook of Pain. 5th ed. Edinburgh: Elsevier Churchill Livingstone; 2005: 1181- 1197.
    Google Scholar
  114. 114
    ↵
    UnruhAM. Gender variations in clinical pain experience. Pain. 1996 May-Jun; 65 2: 123- 167. 8826503
    Google ScholarCrossRefPubMedWeb of Science
  115. 115
    ↵
    BernardesSF, KeoghE, LimaML. Bridging the gap between pain and gender research: a selective literature review. Eur J Pain. 2008 5; 12 4: 427- 440. 17936655
    Google ScholarCrossRefPubMedWeb of Science
  116. 116
    ↵
    BernardesSF, LimaML. Being less of a man or less of a woman: perceptions of chronic pain patients' gender identities. Eur J Pain. 2010 2; 14 2: 194- 199. doi: 10.1016/j.ejpain.2009.04.009. 19467610
    CrossRefPubMed
  117. 117
    ↵
    ForsytheLP, ThornB, DayM, RaceShelby G. and sex differences in primary appraisals, catastrophizing, and experimental pain outcomes. J Pain. 2011 5; 12 5: 563- 572. doi: 10.1016/j.jpain.2010.11.003. 21277836
    CrossRefPubMedWeb of Science
  118. 118
    ↵
    Ramírez-MaestreC, EsteveR. The role of sex/gender in the experience of pain: resilience, fear, and acceptance as central variables in the adjustment of men and women with chronic pain. J Pain. 2014 6; 15 6: 608- 618.e1. doi: 10.1016/j.jpain.2014.02.006. 24632112
    CrossRefPubMed
  119. 119
    ↵
    Ramírez-MaestreC, EsteveR, LópezAE. Cognitive appraisal and coping in chronic pain patients. Eur J Pain. 2008 8; 12 6: 749- 756. 18096418
    Google ScholarCrossRefPubMed
  120. 120
    ↵
    GerbershagenHJ, AduckathilS, van WijckAJ, PeelenLM, KalkmanCJ, MeissnerW. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013 4; 118 4: 934- 944. doi: 10.1097/ALN.0b013e31828866b3. 23392233
    CrossRefPubMedWeb of Science
  121. 121
    ↵
    JoshiGP, KehletH. Procedure-specific pain management: the road to improve postsurgical pain management? Anesthesiology. 2013 4; 118 4: 780- 782. doi: 10.1097/ALN.0b013e31828866e1. 23388191
    CrossRefPubMed
  122. 122
    ↵
    TaenzerP, MelzackR, JeansME. Influence of psychological factors on postoperative pain, mood and analgesic requirements. Pain. 1986 3; 24 3: 331- 342. 3960574
    Google ScholarCrossRefPubMedWeb of Science
  123. 123
    ↵
    De CosmoG, CongedoE, LaiC, PrimieriP, DottarelliA, AcetoP. Preoperative psychologic and demographic predictors of pain perception and tramadol consumption using intravenous patient-controlled analgesia. Clin J Pain. 2008 6; 24 5: 399- 405. doi: 10.1097/AJP.0b013e3181671a08. 18496304
    CrossRefPubMedWeb of Science
  124. 124
    ↵
    RoyseC, RemediosC, RoyseA. High thoracic epidural analgesia reduces the risk of long-term depression in patients undergoing coronary artery bypass surgery. Ann Thorac Cardiovasc Surg. 2007 2; 13 1: 32- 35. 17392668
    Google ScholarPubMed
Loading
Loading
PDF
Back to top

In this issue

Ochsner Journal

Vol. 17, Issue 2

Jun 2017

Table of Contents Index by author

Jump to section

Keywords

Analgesics–opioid, chronic pain, depression, pain, pain perception, psychology